Search Articles — Sudonull

Search Results

In this project

AI destroys copyright: crisis of human authorship

https://sudonull.com/ai-destroys-copyright-crisis-of-human-authorship

Generative AI creates content without a human author, US courts deny protection. Analysis of Thaler v. Perlmutter and the vacuum in law. Read about the future of intellectual property.

From other projects

FDA Fast Track for dendritic cell therapy dubodencel in melanoma

https://ymaho.com/fda-fast-track-for-dendritic-cell-therapy-dubodencel-in-melanoma

FDA granted Fast Track status to dubodencel (DOC1021) therapy for the treatment of unresectable melanoma. Learn how personalized dendritic cell vaccine is changing oncoimmunology.

Loan Goalkeeper Could Deny Parent Club Europe

https://lrivo.com/loan-goalkeeper-could-deny-parent-club-europe

Aston Oxborough's Scottish Cup final performance for Dunfermline could decide Motherwell's European fate. Explore this unique football dilemma.

Ceasefire with Iran: Pentagon deliberately ignores war

https://ymaho.com/ceasefire-with-iran-pentagon-deliberately-ignores-war

Hegseth and Cain deny ceasefire breakdown with Iran, saving markets from collapse. Learn why strikes on UAE are dismissed as 'incidents' and what this threatens. Detailed analysis.

Dubodencel Fast Track: treatment of glioblastoma and pancreatic cancer

https://ymaho.com/dubodencel-fast-track-treatment-of-glioblastoma-and-pancreatic-cancer

Learn how dubodencel received its third Fast Track status from the FDA for treating glioblastoma, pancreatic cancer, and melanoma. Analysis of the dual-loading dendritic cell platform and prospects for patients.

mRNA vaccine against glioblastoma: 42% survival in phase 2

https://ymaho.com/mrna-vaccine-against-glioblastoma-42-survival-in-phase-2

Personalized mRNA vaccine showed 42% 18-month recurrence-free survival in glioblastoma. Learn details of the breakthrough JAMA study and prospects of the method.

Trending Now